CD73 promotes tumor growth and metastasis

OncoImmunology

Volumn 1, Issue 1, 2012, Pages 67-70

  Zhang, Bin ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Adenosine; Adenosine receptors; Cd73; Metastasis; Tumor immunotherapy

Indexed keywords

5' NUCLEOTIDASE; ANTINEOPLASTIC AGENT; CD39 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 41BB; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; APOPTOSIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CELL FUNCTION; CELL INTERACTION; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE SILENCING; HUMAN; IMMUNE RESPONSE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SHORT SURVEY; TUMOR GROWTH;

EID: 84869058675     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.1.1.18068     Document Type: Short Survey

References (30)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; DOI:10.1016/j.cell.2011.02.013.
2. Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 2007; 25:267-96; DOI:10.1146/annurev.immunol.25.022106.141609.
3. Spychala J. Tumor-promoting functions of adenosine. Pharmacol Ther 2000; 87:161-73; DOI:10.1016/S0163-7258(00)00053-X.
4. Zhang B. CD73: A Novel Target for Cancer Immunotherapy. Cancer Res 2010; 70:6407-11; DOI:10.1158/0008-5472.CAN-10-1544.
5. Stagg J, Smyth MJ. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010; 29:5346-58; DOI:10.1038/onc.2010.292.
6. Hoskin DW, Mader JS, Furlong SJ, Conrad DM, Blay J. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells. Int J Oncol 2008; 32:527-35.
7. Sadej R, Spychala J, Skladanowski AC. Ecto-5'-nucleotidase (eN, CD73) is coexpressed with metastasis promoting antigens in human melanoma cells. Nucleosides Nucleotides Nucleic Acids 2006; 25:1119-23; DOI:10.1080/15257770600894188.
8. Sadej R, Inai K, Rajfur Z, Ostapkowicz A, Kohler J, Skladanowski AC, et al. Tenascin C interacts with ecto-5'-nucleotidase (eN) and regulates adenosine generation in cancer cells. Biochim Biophys Acta 2008; 1782:35-40.
9. Ujházy P, Berleth ES, Pietkiewicz JM, Kitano H, Skaar JR, Ehrke MJ, et al. Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance. Int J Cancer 1996; 68:493-500; DOI:10.1002/(SICI)1097-0215(19961115)68:4<493::AID-IJC15>3.0.CO;2- 6.
10. Bavaresco L, Bernardi A, Braganhol E, Cappellari AR, Rockenbach L, Farias PF, et al. The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation. Mol Cell Biochem 2008; 319:61-8; DOI:10.1007/s11010-008-9877-3.
11. Wang L, Zhou X, Zhou T, Ma D, Chen S, Zhi X, et al. Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J Cancer Res Clin Oncol 2008; 134:365-72; DOI:10.1007/s00432-007-0292-z.
12. Jin D, Fan J, Wang L, Thompson LF, Liu A, Daniel BJ, et al. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Res 2010; 70:2245-55; DOI:10.1158/0008-5472.CAN-09-3109.
13. Stagg J, Divisekera U, McLaughlin N, Sharkey J, Pommey S, Denoyer D, et al. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci USA 2010; 107:1547-52; DOI:10.1073/pnas.0908801107.
14. Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci USA 2006; 103:13132-7; DOI:10.1073/pnas.0605251103.
15. Hausler SF, Del Barrio IM, Strohschein J, Chandran PA, Engel JB, Honig A, et al. Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity. Cancer Immunol Immunother 2011.
16. Häusler SF, Ossadnik M, Horn E, Heuer S, Dietl J, Wischhusen J. A cell-based luciferase-dependent assay for the quantitative determination of free extracellular adenosine with paracrine signaling activity. J Immunol Methods 2010; 361:51-6; DOI:10.1016/j.jim.2010.07.011.
17. Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol 2011; 187:676-83; DOI:10.4049/jimmunol.1003884.
18. Yegutkin GG, Marttila-Ichihara F, Karikoski M, Niemela J, Laurila JP, Elima K, et al. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression. Eur J Immunol 2011; 41:1231-41; DOI:10.1002/eji.201041292.
19. Stagg J, Divisekera U, Duret H, Sparwasser T, Teng MW, Darcy PK, et al. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Res 2011; 71:2892-900; DOI:10.1158/0008-5472.CAN-10-4246.
20. Wang L, Fan J, Thompson LF, Zhang Y, Shin T, Curiel TJ, et al. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest 2011; 121:2371-82; DOI:10.1172/JCI45559.
21. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204:1257-65; DOI:10.1084/jem.20062512.
22. Ålgars A, Karikoski M, Yegutkin GG, Stoitzner P, Niemela J, Salmi M, et al. Different role of CD73 in leukocyte trafficking via blood and lymph vessels. Blood 2011; 117:4387-93; DOI:10.1182/blood-2010-11-321646.
23. Sitkovsky MV, Kjaergaard J, Lukashev D, Ohta A. Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia. Clin Cancer Res 2008; 14:5947-52; DOI:10.1158/1078-0432.CCR-08-0229.
24. Auchampach JA. Adenosine receptors and angiogenesis. Circ Res 2007; 101:1075-7; DOI:10.1161/CIRCRESAHA.107.165761.
25. Enjyoji K, Sevigny J, Lin Y, Frenette PS, Christie PD, Esch JS 2nd, et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 1999; 5:1010-7; DOI:10.1038/12447.
26. + regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology 2010; 139:1030-40; DOI:10.1053/j.gastro.2010.05.007.
27. Künzli BM, Bernlochner MI, Rath S, Kaser S, Csizmadia E, Enjyoji K, et al. Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic Signal 2011; 7:231-41; DOI:10.1007/s11302-011-9228-9.
28. Ryzhov S, Novitskiy SV, Zaynagetdinov R, Goldstein AE, Carbone DP, Biaggioni I, et al. Host A(2B) adenosine receptors promote carcinoma growth. Neoplasia 2008; 10:987-95.
29. Gessi S, Merighi S, Sacchetto V, Simioni C, Borea PA. Adenosine receptors and cancer. Biochim Biophys Acta 2011; 1808:1400-12.
30. Ohta A, Sitkovsky M. Caveats and cautions for the therapeutic targeting of the anti inflammatory A2 adenosine receptors: The notes of caution. Nat Rev Drug Discov 2006; 5.